NASDAQ · STOCK
Bristol Myers Squibb
$57.56
52W $42.52 – $62.89
70/100
$118.35B
19.9
0.23
Price History (6M)
Executive Summary
7 analysts weighed in with 57% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Risk Analyst: High leverage (debt-to-equity 2.44) amplifies downside in a stress scenario. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
70/100
Agreement
80%
Analysts
5
Conviction
High
Value Analyst
neutral
50
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 41.6% shows genuine earnings power backing the valuation
− Price-to-book of 5.9x prices in significant intangible value
Growth Analyst
bullish
72
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 26.3% YoY
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.44) amplifies downside in a stress scenario
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
53.8
Neutral
MACD Histogram
0.203
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Lh Ll
Support
$56.91
Resistance
$60.20
Bollinger %B
0.69
Inside Bands
Price vs Moving Averages
EMA 9
$57.37
Above
EMA 21
$56.96
Above
EMA 50
$57.04
Above
EMA 200
$55.36
Above
Fundamental Analysis
Valuation
56
Growth
72
Profitability
83
Financial Health
20
Valuation
P/E Ratio
19.9×
P/B Ratio
5.94×
PEG Ratio
—
Dividend Yield
4.35%
52W High
$62.89
52W Low
$42.52
Quality & Growth
ROE
4164.0%
ROA
868.0%
Gross Margin
5371.0%
Operating Margin
1710.0%
Revenue Growth YoY
+178.0%
Debt / Equity
2.44
AI Fundamental Assessment
P/E ratio of 19.9 (inexpensive relative to a 15-40x range); Price-to-book of 5.9x; Revenue growth (YoY) of 1.8%; EPS growth (YoY) of 26.3%; Return on equity of 41.6%; Return on assets of 8.7%; Net margin of 12.3%; Gross margin of 53.7%; Current ratio of 1.26 (tight short-term liquidity); Debt-to-equity of 2.44; Most recent quarter beat estimates by 10.4%; 4 consecutive earnings beats; EPS growth accelerating (-22.7% -> +25.4% QoQ); Analyst estimates falling over recent quarters
Key Risks
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full BMY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile